Insight Molecular Diagnostics, Inc. (IMDX)
6.185
+0.62
(+11.24%)
USD |
NASDAQ |
May 20, 16:00
5.85
-0.34
(-5.42%)
After-Hours: 20:00
Insight Molecular Diagnostics Free Cash Flow : -27.46M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Veracyte, Inc. | 155.34M |
| Exagen, Inc. | -14.13M |
| bioAffinity Technologies, Inc. | -10.93M |
| GRAIL, Inc. | -292.33M |
| FONAR Corp. | 4.167M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.639M |
| Cash from Investing (Quarterly) | -0.613M |
| Cash from Financing (Quarterly) | 24.70M |
| Free Cash Flow Per Share (Quarterly) | -0.2391 |
| Free Cash Flow to Equity (Quarterly) | -7.824M |
| Free Cash Flow to Firm (Quarterly) | -8.229M |
| Free Cash Flow Yield | -13.59% |